Abstract Purpose: To evaluate the antidiarrhea and antioxidant properties of honokiol extracted from Magnoliae officinalis cortex (bark of Magnolia officinalis), an important medical material in traditional Chinese 16 % in comparison with -neostigmine control group-(59.0 % vs. 70
INTRODUCTION
. The Magnoliae officinalis cortex has long been used as a popular ingredient in several Chinese traditional remedies for the treatment of diseases, including thrombotic stroke, typhoid fever, diarrhea, anxiety, nervous disturbance and asthma.
Although Magnoliae officinalis cortex has been used as the main ingredient in remedies for the treatment of diarrhea in traditional Chinese medicine, there is no report on the antidiarrhea activity of this plant material per se. Pan et al demonstrated that Huanglian Houpu pill (HLHP) inhibited senna-induced diarrhea in mice [2] . Hu et al also reported that the methanol extract of Wei-Chang-An-Wan (WCAW) protected mice against castor oil-induced diarrhea [3] . WCAW, a typical Chinese herbal preparation, consists of ten herbs, including cortex Magnolia officinalis. Since many traditional Chinese medicines or prescriptions for clinical treatment of diarrhea, including HLHP and WCAW, contain Magnoliae officinalis cortex, it is probable that Magnoliae officinalis cortex plays an important role in the antidiarrheal effect of many traditional medicines; however, the active component(s) and mechanism of action of several of the traditional Chinese antidiarrheal medicines are yet to be elucidated.
Honokiol is a bioactive constituent in Magnoliae officinalis cortex and recent investigations have shown that honokiol possess a wide range of physiological activities, such as antitumor [4] , antimicrobial [5] , and antiinflammatory activity [6] . Antioxidant activity in vitro of Magnoliae officinalis cortex and honokiol have also been reported [7, 8] .
We hypothesied that honokiol in Magnoliae officinalis cortex is the primary ingredient involved in both antidiarrheic and antioxidative activity. In this study, therefore, we used a mouse model to investigate the effects of the honokiol extract on castor oil-induced diarrhea, on charcoal transit rate in the small intestines. Furthermore, influence of the honokiol extract on antioxidative enzymes activities and gene expression levels, as well as markers of antioxidant status in plasma and liver of mice were also evaluated. The bark was dried and ground to pass through a 30 -mesh sieve. This powder was extracted with 60 % ethanol for 2.5 h at room temperature. The supernatant was concentrated by rotary evaporation at 40 °C and the residue freezedried. The dried extract was referred to as the crude extract. The purity of honokiol in the crude extract was 89.3 %, as measured by high performance liquid chromatography (HPLC).
EXPERIMENTAL Animals
The crude extract was reconstituted in 60 % ethanol and further purified with HP-20 macroporous absorbing resin. The eluent containing honokiol was collected by fraction collector. The solvent was removed by rotary evaportion at -0.05 MPa at 70 °C and the residue freeze-dried. This procedure increased the purity to 91.3 % by HPLC. The extracted honokiol was dissolved in 2 % aqueous Tween 80 solution (V/V) immediately prior to oral administration to the mice.
Drugs/chemicals
Castor oil was obtained from Tianjin Fuchen Chemicals Reagent Factory (B.N. 20070704). Loperamide hydrochloride, a medicine for treatment of diarrhea, was provided by XianJanssen Pharmaceutical Ltd (B.N. 09041541). Neostigmine was obtained from Shandong Tianfu Pharmaceutical Ltd (batch no. 080701). Glutathione peroxidase (GSH-Px), total superoxide dismutase (T-SOD), catalase (CAT), glutathione (GSH) and total antioxidant capacity (T-AOC) assay kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Power SYBR Green PCR Master Mix was obtained from Applied Biosystems (CA, USA).
Test for antidiarrhea activity

Castor oil-induced diarrhea
A diarrhea model in mice was established by single oral administration (by gavage) of castor oil at dose of 20 ml/kg body weight (BW) [9] . Sixty mice were fasted for 24 h and randomly allocated into six equal groups based on BW. Both control group and model control group orally received saline (0.9 % W/V sodium chloride) (20 ml/kg BW). The positive control group was orally administered with loperamide hydrochloride (Xian-Janssen Pharmaceutical, Ltd. B.N. 09041541) 3 mg/kg BW according to the medicine package insert. The remaining three groups were orally administered by gavage with the honokiol extract solution at doses of 25 (Honokiol 25), 50 (Honokiol 50) or 100 (Honokiol 100) mg honokiol/kg BW respectively at the same volume. The dose setting of honokiol in this study referred to results of Hsieh et al [10] , Atanasov et al [11] and Pang et al [12] .
Then 30 min after treatment, all mice, except for the control, were orally administered with castor oil. The control mice received an equivalent oral volume of saline. Then animals were placed in individual cages, the floor of which was covered with filter paper that was replaced hourly. The numbers and morphology of the stools were recorded for 6 h after the administration of castor oil. The total number of stools over the 6 h was determined. The severity of diarrhea was defined using three indices: loose stool incidence rate (LSIR), average loose stool grade (ALSG) and diarrhea index (DI) [13] . LSIR is the ratio of number of loose stools to the total stools within an animal. Loose stool grade (LSG) describes the degree of loose stools, based on the diameter of the stool on the filter papers. LSG was classified into four grades according the diameter of loose stools: Grade 1 (< 1 cm), Grade 2 (1 ~ 1.9 cm), Grade 3 (2 ~ 3 cm), and Grade 4 (> 3 cm). ALSG is the ratio of the sum of LSG of each loose stool to the total number of loose stools within an animal. DI is the result of LSR multiplying ALSG. [13] Effect on charcoal transit in the small intestines The effect of honokiol on gastrointestinal motility was tested by measuring charcoal transit in the small intestines of the mice [14] . Healthy Kunming mice were randomly divided into five groups based on BW with ten mice per group. The 5 groups were control (saline throughout), neostigmine (saline plus neostigmine treatment) and three honokiol groups (honokiol plus neostigmine treatment). The 3 honokiol groups were orally administered by gavage with the honokiol extract solution at 20 ml/kg BW to supply doses of 25 (Honokiol 25), 50 (Honokiol 50) or 100 (Honokiol 100) mg/kg BW, respectively. The control and neostigmine groups were both administered with saline at dose of 20 ml/kg BW. Honokiol and saline were administered once per day for 4 days. On day 4, all mice, except for control group, were administered with neostigmine (0.15 mg/kg BW by intraperitoneal injection according to the medicine package insert) 30 min after the oral administration of honokiol or saline. Then 20 min later, all mice, including those in normal control group, were orally administered with charcoal meal (5 % (W/V) charcoal suspension in a 1 % (W/V) carboxy methyl cellulose solution) at dose of 10 ml/kg BW [15] . Then 20 min after the charcoal meal, all animals were sacrificed by cervical dislocation. The small intestine was removed immediately and total length measured. The distance (cm) that the charcoal meal had travelled from the pylorus into the intestinal lumen was measured, and small intestinal transit (SIT) of the charcoal was expressed as the percentage of the longest distance travelled by the charcoal divided by the length of the small intestine [16] .
Test for antioxidative activity
Animals and treatment
Forty male Kunming mice were randomly divided into five equal groups: the control group orally received 2 % aqueous Tween 80 solution; the positive control group orally received 50 mg/kg BW vitamin E dissolved in 2 % aqueous Tween 80 solution [17] ; the three honokiol-treatment groups orally received the honokiol extract at doses of 25, 50 or 100 mg/kg BW respectively. The solvent, vitamin E and the honokiol extract were orally administered once per day for 14 days [18] . All dose volumes were the same. On the morning of day 15 of the treatment, all mice were anesthetized with ether. Blood sample (about 0.2 to 0.3 ml per mouse) was collected via retro-orbital bleeding into heparinized tubes prior to cervical dislocation. Plasma was separated by centrifuging at 1200 g for 10 min and stored at -20 °C until analysis of activity of antioxidative enzymes. Then the liver was rapidly removed under aseptic condition, washed in cold saline, chopped and frozen in liquid nitrogen. The liver sample was stored at -70 °C until further analysis.
Chemical analysis
The activities of glutathione peroxidase (GSHPx), total superoxide dismutase (T-SOD) and catalase (CAT) in both the plasma and liver, and glutathione (GSH) concentration and total antioxidant capacity (T-AOC) in the liver were measured using commercial available kits (Nanjing Jiancheng Bioengineering Institute).To analyse the liver sample, the sample was homogenized in 9 volumes of ice-cold saline. The homogenate was then centrifuged at 1200 g at 4 °C for 10 min. The supernatant was used for all assays performed according to the manufacturer's instructions. The CAT activity was determined spectrophotometrically using the method of Goth [19] . The SOD activity was measured spectrophotometrically according to the method of Flohé and Otting [20] . The GSHPx activity was determined using the method described by Lawrence and Burk [21] . The GSH concentration was measured spectrophotometrically with the procedures described by Sedlak and Lindsay [22] . The T-AOC was measured based on the method of Benzie and Strain [23] .
Gene expression analysis
The expression of CAT, GSH-Px, copper-zinc SOD (Cu/Zn-SOD), manganese SOD (Mn-SOD), and extracellular SOD (EC-SOD) at RNA levels in the liver were determined by using quantitative real-time PCR (qPCR). qPCR was performed on the ABI 7900 HT fast real-time PCR system (Applied Biosystems, CA, USA) and the qPCR primers of Pang et al were used [12] .
The qPCR reactions were conducted in triplicate using a 10 μL reaction mixture containing 5 μL 2 × Power SYBR Green PCR Master Mix, 0.1 μL cNDA template, 0. 
Statistical analysis
The data were analyzed by using ANOVA procedures, followed by Dunnett's comparisons test using SAS software (version 8, SAS Institute, Cary, NC, USA). The least square means ± SD of the data are presented. Differences between the honokiol extract treatment and controls were considered at p < 0.05.
RESULTS
Inhibition of honokiol on castor oil-induced diarrhea
ALSG did not differ between model control, positive control and honokiol treatment groups (Table 1) . When compared with the model group, the honokiol treatments had lower LSR and DI values (p < 0.001); whereas the values were higher in comparison with the positive control (p < 0.001). No differences in LRS and DI were found between the three honokiol groups.
Effect of honokiol on small intestinal transit (SIT)
There were no differences in the small intestine length between groups (Table 2) . When compared with the control group, the honokiol treatments did not change the distance travelled by charcoal, but increased SIT (p < 0.01). In comparison with the neostigmine group, the SIT values for the honokiol groups were lower (p < 0.01). Neostigmine treatment produced greatest (p < 0.01) distance travelled by charcoal and high SIT when compared with the control. Between the three honokiol groups there were no differences either in the charcoal distance travelled or the SIT.
Effect of honokiol on the activity of antioxidant enzymes in plasma
The impact of honokiol on antioxidant enzymes in plasma are shown in Figure 1 . The activities (U/mL) of CAT, GSH-Px and T-SOD in the three honokiol groups were higher (p < 0.01) than those in the control group. There were no differences in the activities of CAT, GSH-Px and T-SOD between honokiol groups and the vitamin E treated control. No differences were observed in the activity of the three antioxidant enzymes between the honokiol groups.
Effect of honokiol on antioxidant status in mouse liver
When compared with the control group, the activities of CAT, GSH-Px and T-SOD in the three honokiol groups were greater (p < 0.01), T-AOC was higher only in the Honokiol 100 group (p < 0.001), but GSH concentration were similar (Table 3) . Compared with the positive control, CAT activities were higher in Honokiol 50 and 100 groups (p < 0.05) and T-AOC was greater for the Honokiol 100 group only (p < 0.05). In addition, T-AOC of Honokiol 100 was greater (p < 0.01) than those of Honokiol 25 and 50, but GSH concentration and activities of CAT, T-SOD, and GSH-Px were similar for all three honokiol groups. 
Effects of honokiol on mRNA abundance of antioxidant enzymes in the liver
When compared with the control, the gene expression of CAT was greater for the Honokiol 100 group only (p < 0.05); the gene expression of GSH-Px was greater in Honokiol 50 and 100 groups (p < 0.05), but no differences were found in the gene expressions of Cu/Zn-SOD, Mn-SOD and EC-SOD (Table 4) . When compared with the positive control, the gene expression of CAT was lower in the Honokiol 50 group (p < 0.05), the gene expression of GSH-Px was lower in the Honokiol 25 and 50 groups (p < 0.01), but there was no difference in the mRNA abundance for Cu/Zn-SOD, Mn-SOD and EC-SOD in the honokiol-treated groups. Honokiol 100 mice had the greatest mRNA abundance for CAT and GSH-Px among the three honokiol groups. Furthermore, CAT gene expression in the Honokiol 50 was lower (p < 0.001) than that for Honokiol 100, while GSH-Px expression of the Honokiol 25 group was also lower (p < 0.001) than that for Honokiol 100.
DISCUSSION
Honokiol is one of two major groups of bioactive compounds isolated from the cortex of Magnolia officinalis. The current study shows, for the first time, that the honokiol extracted from cortex Magnolia officinalis reduces the severity of diarrhea induced by castor oil, as indicated by the reduction of the loose stool rate and diarrhea index in mice.
Castor oil causes diarrhea in animals due to the action of its active metabolite, ricinoleic acid, derived from hydrolysis of its triglyceride in the duodenum by pancreatic lipase. The released ricinoleic acid causes irritation and inflammation of the intestinal mucosa and also stimulates intestinal hypermotility and hypersecretion. These series of actions lead to diarrhea [24, 25] .Since the honokiol extract successfully reduced severity of diarrhea induced by castor oil in this study, honokiol may therefore exert its antidiarrhea actions via antiinflammatory, antihypermotility or anti-hypersecretion activities
In this study honokiol showed anti-hypermotility actions as evident from the inhibition of the increased intestinal transit induced by neostigmine (a medicine for improving smooth muscle tone), which showed that honokiol has intestinal smooth muscle relaxation quality. Honokiol has been reported to relax smooth muscle in the porcine trachea [26] . Honokiol also inhibits the contractility of isolated gastric fundus strips of rats and the isolated ileum of guinea pigs, through a mechanism thought to be associated with a calcium-antagonistic effect [27] . The retardation of hyperactive intestinal Table 3 : Effect of honokiol on antioxidant status in the liver of mice (n = 8)
Group
An alternative mechanism for honokiol action might be as a Ca 2+ transport antagonist. Lu et al reported that honokiol inhibited uterine contraction in rats by blocking external Ca 2+ influx [28] . The relaxant effect of honokiol on the tracheal smooth muscle of pig also involved blockade of Ca 2+ influx through voltage-operated Ca 2+ channels instead of Ca 2+ release from intracellular Ca 2+ stores [26] . Consequently, honokiol may be considered a putative calcium antagonist or calcium channel blocker. Calcium is involved in secretory diarrhea by modulating secretion of chloride or potassium, and gut motility also appears mediated by calcium flux [29, 30] . As a calcium antagonist, honokiol may have both antimotility and antisecretory effects, both of which might help alleviate diarrhea.
Taken as a whole, the antidiarrheal activity of honokiol may involve integration of multiple mechanisms, among which, the retardation of small intestinal transit and Ca 2+ -channel block may be included. The exact mechanism will require further investigation. The current studies indicate that honokiol exerts significant antidiarrheal and antimotility activity. Furthermore, our previous studies have also showed that magnolol has both antidiarrheal and antimotility effects [12] . Honokiol and magnolol are two biphenolic compounds. The contents of honokiol and magnolol in cortex Magnoliae officinalis contex were 1.2 % and 0.9 %, respectively [31] . Honokiol and magnolol are commonly seen as two major bioactive constituents of Magnoliae officinalis cortex. The antidiarrheal and antimotility functions of honokiol and magnolol could possibly explain the reason for Magnoliae officinalis cortex being contained in many traditional Chinese medicines or prescriptions for treating diarrhea. The results in this study may provide reference to prepare some Chinese patent drugs or herbal extract medicines of Magnoliae officinalis cortex to treat diarrhea.
The Magnoliae officinalis cortex has been found to have antioxidant properties in vitro [7] . In this study, CAT, GSH-Px and SOD activities in both plasma and liver of mice were all increased by the honokiol extract. These changes were accompanied by elevated mRNA abundance for CAT and GSH-Px, and the expression levels of CuZn-SOD, Mn-SOD and EC-SOD genes in the honokiol extract-treated mice were numerically higher than that in control mice. Therefore, an administration of the honokiol extract to mice induced the increment in CAT, GSH-Px and T-SOD activities possibly by up-regulating the expression of genes of antioxidant enzymes.
GSH in tissues plays a central role in the antioxidant defense system through direct detoxification ROS or via a GSH-Px catalyzed mechanism. The physiological role of GSH is as an essential intracellular reducing agent for the maintenance of reducing state of thiol groups and other antioxidant molecules. The results of the present study demonstrated that the honokiol extract tended to increase GSH concentration in the liver of mice, in a linear dose-dependent manner (p < 0.01, R 2 = 0.981). Honokiol has been found to have a protective effect against Dgalactosamine-induced hepatotoxicity, which is used as an alternate model to oxidative stress, acting by inhibiting intracellular GSH depletion [32] .
Total antioxidant capacity (T-AOC) reflects the capacity of the non-enzymatic antioxidant defense system. Only at the highest dose of honokiol extract, was T-AOC increased for the liver. The results showed that the honokiol extract at appropriate dose increased the activities of both the non-enzymatic and enzymatic anti-oxidant defense systems and has potential for use as a natural antioxidant.
CONCLUSION
The findings of this demonstrate that honokiol extract possesses antidiarrheal activities, which likely contribute to the antidiarrheal efffect of Magnolia officinalis cortex in Chinese traditional medicine. The enhancement effects of honokiol extract on both the non-enzymatic and enzymatic anti-oxidant defense systems required to unravel its mechanisms of action.
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